74 results on '"Banno, E."'
Search Results
2. The association between human gut microbiota and prostate enlargement
3. Lipopolysaccharide from gut microbiota promotes prostate cancer growth through histamine H1 receptor signaling
4. Firmicutes in gut microbiota correlate with blood testosterone levels in elderly men
5. C27 - Estrogen receptor mutation: a new strategy to overcome endocrine resistance
6. A45 - The regorafenib issue: focus on efficacy and safety in pre-treated metastatic colorectal cancer from a real world experience
7. An activating ALK gene mutation in ALK IHC-positive/FISH-negative nonsmall-cell lung cancer
8. Determination of Spatially Hybridized Charge Distribution and its Effect on Electron Transport in the Al-Cu-Ru-Si 1/1-Approximant–Theoretical Basis for the Hume-Rothery rule–
9. Interplay of atomic and electronic structures in RT- and MI-type 1/1-approximants: why does the Hume-Rothery rule work?
10. 259 Fibroblast growth factor 9 gene amplification can induce resistance to anti-EGFR therapy in colorectal cancer
11. E35 - Efficacy and safety of immune checkpoint inhibitor nivolumab and radiotherapy combination in advanced NSCLC
12. A18 - Efficacy of anti-EGFR antibodies combined with chemotherapy for elderly patients with RAS wild-type metastatic colorectal cancer: a systematic review and metanalysis
13. 525P - Efficacy of anti-EGFR antibodies combined with chemotherapy for elderly patients with RAS wild-type metastatic colorectal cancer: A systematic review and metanalysis
14. S30 - Can irinotecan dose reduction according to ugt1a1 genotype avoid severe toxicities?
15. G09 - Multidisciplinary management in ovarian cancer
16. A28 - TILs evaluation in early stages of NSCLC
17. Fast Wavelength Switching of Fully Heater-tuned CSG-DR Lasers
18. 6.25 GHz Flexible Grid Tuning of Fully Heater-tuned CSG-DR Lasers with Sub-millisecond Wavelength Switching
19. Cytomegalovirus Infection after Prophylactic Valganciclovir Therapy Post–Kidney Transplantation: Case Reports
20. Suppression of channel-by-channel variation in wavelength switching time of TDA-CSG-DR laser.
21. Fast wavelength switching of fully heater-tuned CSG-DR lasers.
22. Optical feed-forward carrier recovery using semiconductor optical devices and low frequency electronics
23. Suppression of Channel-by-Channel Variation in Wavelength Switching Time of TDA-CSG-DR Laser
24. Autonomously Controlled All-Optical Signal Conditioning for Dynamic Optical Path Networks
25. Dynamic Parametric Dispersion Compensation Using FPGA Pump Controller and Dispersion Monitor
26. Fast Wavelength Switching of Fully Heater-tuned CSG-DR Lasers
27. A0591 - The association between human gut microbiota and prostate enlargement.
28. A0426 - Lipopolysaccharide from gut microbiota promotes prostate cancer growth through histamine H1 receptor signaling.
29. An activating ALK gene mutation in ALK IHC-positive/FISHnegative nonsmall-cell lung cancer.
30. Sex differences in lower urinary tract function in mice with or without spinal cord injury.
31. External beam radiotherapy combination is a risk factor for bladder cancer in patients with prostate cancer treated with brachytherapy.
32. Immunohistochemical Analysis of HER2, EGFR, and Nectin-4 Expression in Upper Urinary Tract Urothelial Carcinoma.
33. The pressure flow study investigation of pathophysiology of post-micturition dribble in male patients.
34. The Association of Tumor Immune Microenvironment of the Primary Lesion with Time to Metastasis in Patients with Renal Cell Carcinoma: A Retrospective Analysis.
35. Targeted-sequence of normal urothelium and tumor of patients with non-muscle invasive bladder cancer.
36. EphA2 on urinary extracellular vesicles as a novel biomarker for bladder cancer diagnosis and its effect on the invasiveness of bladder cancer.
37. Prognostic factors in Japanese men with high-Gleason metastatic castration-resistant prostate cancer.
38. Gut microbiome and prostate cancer.
39. Firmicutes in Gut Microbiota Correlate with Blood Testosterone Levels in Elderly Men.
40. Disseminated intravascular coagulation induced by pazopanib following combination therapy of nivolumab plus ipilimumab in a patient with metastatic renal cell carcinoma.
41. The Firmicutes/Bacteroidetes ratio of the human gut microbiota is associated with prostate enlargement.
42. Context-Specific Efficacy of Apalutamide Therapy in Preclinical Models of Pten -Deficient Prostate Cancer.
43. The gut microbiota associated with high-Gleason prostate cancer.
44. Higher neutrophil-to-lymphocyte ratio after the first cycle of the first-line chemotherapy is associated with poor cancer specific survival of upper urinary tract carcinoma patients.
45. Telomerase reverse transcriptase promoter mutation in tumorigenesis of bladder cancer: Evolutionary trajectory by algorithmic inference from cross-sectional data.
46. Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial Carcinoma.
47. Reactivation of latent tuberculosis infection induced by cabazitaxel in a patient with prostate cancer: A case report.
48. Clinical significance of Akt2 in advanced pancreatic cancer treated with erlotinib.
49. Significance of FGF9 gene in resistance to anti-EGFR therapies targeting colorectal cancer: A subset of colorectal cancer patients with FGF9 upregulation may be resistant to anti-EGFR therapies.
50. MEK inhibitors against MET-amplified non-small cell lung cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.